In addition, clinical studies have demonstrated success with radioactive GRP-analogs and GRP-R antagonists for both diagnostic tumor imaging and radiotherapy of GRP-R-overexpressing cancers [37, 39–41]. The gene discussed is GRPR; the disease is neoplasm.